AB
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Late-onset pulmonary complications following allogeneic hematopoietic cell transplantation in pediatric patients : a prospective multicenter study | Bone marrow transplantation |  | 2024 | 44 | 0 | ||
| Effect of cyclosporin A on respiratory viral replication in fully differentiated ex vivo human airway epithelia | Pharmacology research & perspectives |  | 2024 | 117 | 88 | ||
| Isavuconazole for the Treatment of Fungal Infections : A Real-life Experience From the Fungal Infection Network of Switzerland (FUNGINOS) | Open forum infectious diseases | | 2024 | 78 | 97 | ||
| Detection of Bronchiolitis Obliterans Syndrome after Pediatric Hematopoietic Stem Cell Transplantation : An Official American Thoracic Society Clinical Practice Guideline | American journal of respiratory and critical care medicine | | 2024 | 56 | 49 | ||
| Immunomodulators for immunocompromised patients hospitalized for COVID-19: a meta-analysis of randomized controlled trials | EClinicalMedicine | | 2024 | 94 | 10 | ||
| CT Imaging Assessment of Response to Treatment in Allergic Bronchopulmonary Aspergillosis in Adults With Bronchial Asthma | Chest | | 2024 | 52 | 4 | ||
| Prophylaxie de l’infection à Pneumocystis jirovecii chez les patients non VIH : Évaluation du risque et des modalités | Revue médicale suisse | | 2024 | 66 | 0 | ||
| Human metapneumovirus infection is associated with a substantial morbidity and mortality burden in adult inpatients | Heliyon | | 2024 | 90 | 55 | ||
| Diagnosis of Post-Hematopoietic Stem Cell Transplantation Bronchiolitis Obliterans Syndrome in Children : Time for a Rethink? | Transplantation and cellular therapy | | 2024 | 47 | 15 | ||
| ERS/EBMT clinical practice guidelines on treatment of pulmonary chronic graft-versus-host disease in adults | European respiratory journal | | 2024 | 61 | 341 | ||
| Noninfectious pulmonary complications | The EBMT Handbook : Hematopoietic Cell Transplantation and Cellular Therapies | | 2024 | 82 | 91 | ||
| Recommendations for surveillance of pulmonary dysfunction among childhood, adolescent, and young adult cancer survivors : a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group | EClinicalMedicine | | 2024 | 23 | 33 | ||
| Pulmonary fibrosis in patients with autoimmune pulmonary alveolar proteinosis: a retrospective nationwide cohort study | ERJ open research | | 2024 | 63 | 60 | ||
| Nouveautés dans le diagnostic et le traitement de la pneumonie acquise en communauté | Revue médicale suisse | | 2024 | 123 | 0 | ||
| Pitfalls in definitions on respiratory viruses and particularities of Adenovirus infection in hematopoietic cell transplantation patients : Recommendations from the EBMT practice harmonization and guidelines committee | Current research in translational medicine | | 2024 | 50 | 40 | ||
| Inefficient antiviral response in reconstituted small-airway epithelium from chronic obstructive pulmonary disease patients following human parainfluenza virus type 3 infection | Virology journal | | 2024 | 87 | 43 | ||
| Soins palliatifs précoces dans les maladies respiratoires chroniques | Revue internationale de soins palliatifs | | 2023 | 58 | 0 | ||
| Interstitial lung diseases after hematopoietic stem cell transplantation: New pattern of lung chronic graft-versus-host disease ? | Bone marrow transplantation | | 2023 | 118 | 154 | ||
| Respiratory recovery trajectories after severe-to-critical COVID-19: a 1-year prospective multicentre study | European respiratory journal | | 2023 | 93 | 86 | ||
| Infections in autoimmune pulmonary alveolar proteinosis: a large retrospective cohort | Thorax | | 2023 | 84 | 0 | ||
| Bronchiolitis obliterans syndrome following SARS-CoV-2 infection in an allogeneic hematopoietic stem cell recipient | American journal of transplantation | | 2023 | 304 | 179 | ||
| Late-Onset Interstitial Lung Disease Following Allogeneic Hematopoietic Stem Cell Transplantation | Pulmonary and Critical Care Considerations of Hematopoietic Stem Cell Transplantation | | 2023 | 41 | 0 | ||
| 18F-FDG uptake by respiratory muscles in acute respiratory insufficiency in a patient with graft versus host disease | Respiratory medicine and research | | 2023 | 93 | 0 | ||
| Impact of the COVID-19 pandemic on antiviral drug development for other community-acquired respiratory viruses’ infections | Thérapie | | 2023 | 84 | 457 | ||
| Prise en charge palliative précoce de la dyspnée dans les maladies pulmonaires | Revue médicale suisse | | 2023 | 106 | 30 | ||
| Liver disease in germline mutations of telomere-related genes : prevalence, clinical, radiological, pathological features, outcome, and risk factors | Hepatology | | 2023 | 125 | 160 | ||
| Bronchial aspirate obtained during bronchoscopy yields increased fungal load compared to bronchoalveolar lavage fluid in patients at risk of invasive aspergillosis and Pneumocystis pneumonia | Medical mycology | | 2023 | 114 | 0 | ||
| Bronchiolitis obliterans syndrome | Pulmonary and Critical Care Considerations of Hematopoietic Stem Cell Transplantation | | 2023 | 25 | 0 | ||
| Immunocompromised Host Pneumonia: Definitions and Diagnostic Criteria: An Official American Thoracic Society Workshop Report | Annals of the American Thoracic Society | | 2023 | 80 | 366 | ||
| Circulating T cell profiles associate with enterotype signatures underlying hematological malignancy relapses | Cell host & microbe | | 2023 | 85 | 0 | ||
| 2022 Update of indications and contraindications for lung transplantation in France | Respiratory medicine and research | | 2023 | 140 | 0 | ||
| Atypical imaging patterns during lung invasive mould diseases: lessons for clinicians | European respiratory review | | 2023 | 103 | 70 | ||
| Azithromycin promotes relapse by disrupting immune and metabolic networks after allogeneic stem cell transplantation | Blood | | 2022 | 123 | 54 | ||
| Amikacin Liposomal Inhalation Suspension in the Treatment of Mycobacterium abscessus Lung Infection: A French Observational Experience | Open forum infectious diseases | | 2022 | 142 | 107 | ||
| Déficit en alpha-1-antitrypsine | Revue médicale suisse | | 2022 | 146 | 428 | ||
| Severe COVID-19 is associated with hyperactivation of the alternative complement pathway | Journal of allergy and clinical immunology | | 2022 | 107 | 69 | ||
| Bronchiolitis obliterans syndrome after lung or haematopoietic stem cell transplantation: current management and future directions | ERJ open research | | 2022 | 66 | 257 | ||
| Nebulised liposomal amphotericin-B as maintenance therapy in allergic bronchopulmonary aspergillosis: a randomised, multicentre trial | European respiratory journal | | 2022 | 180 | 0 | ||
| Unis pour être meilleurs | Revue médicale suisse | | 2022 | 62 | 30 | ||
| Active Surveillance Program to Increase Awareness on Invasive Fungal Diseases: the French RESSIF Network (2012 to 2018) | MBio | | 2022 | 94 | 147 | ||
| Epigenetic changes in human model KMT2A leukemias highlight early events during leukemogenesis | Haematologica | | 2022 | 106 | 90 | ||
| Antifungal Prophylaxis in AML Patients Receiving Intensive Induction Chemotherapy: A Prospective Observational Study From the Acute Leukaemia French Association (ALFA) Group | Clinical lymphoma myeloma & leukemia | | 2022 | 78 | 0 | ||
| Mycobacterial infections in adults with haematological malignancies and haematopoietic stem cell transplants: guidelines from the 8th European Conference on Infections in Leukaemia | The Lancet. Infectious diseases | | 2022 | 122 | 0 | ||
| Sarilumab in adults hospitalised with moderate-to-severe COVID-19 pneumonia (CORIMUNO-SARI-1): An open-label randomised controlled trial | The Lancet. Rheumatology | | 2022 | 17 | 4 | ||
| Transplantation pulmonaire en France : actualisation des indications et contre-indications en 2022 | Revue des maladies respiratoires | | 2022 | 76 | 0 | ||
| Dasatinib dose optimisation based on therapeutic drug monitoring reduces pleural effusion rates in chronic myeloid leukaemia patients | British journal of haematology | | 2021 | 31 | 0 | ||
| Evaluation of prognostic scores for respiratory syncytial virus infection in a French multicentre cohort of allogeneic haematopoietic stem cell transplantation recipients | Bone marrow transplantation | | 2021 | 149 | 104 | ||
| National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2020 Highly morbid forms report | Transplantation and cellular therapy | | 2021 | 26 | 62 | ||
| Profiles and outcomes in patients with COVID-19 admitted to wards of a French oncohematological hospital : A clustering approach | PloS one | | 2021 | 23 | 25 | ||
| Characteristics and mid-term follow-up of COVID-19 patients with hematological diseases : a retrospective study from a French tertiary care hospital | Blood cancer journal | | 2021 | 122 | 16 | ||
| Pulmonary hypertension in patients with common variable immunodeficiency | Journal of clinical immunology | | 2021 | 16 | 0 | ||
| Frequent lower respiratory tract disease in hematological patients with parainfluenza virus type 3 infection | Journal of medical virology | | 2021 | 37 | 0 | ||
| Pulmonary Alveolar Proteinosis After Allogeneic Hematopoietic Stem-Cell Transplantation in Adults : A French Société Francophone de Greffe de Moelle et Thérapie Cellulaire Survey | Chest | | 2021 | 26 | 17 | ||
| Prospective comparison of (1,3)-beta-D-glucan detection using colorimetric and turbidimetric assays for diagnosing invasive fungal disease | Medical mycology | | 2021 | 32 | 16 | ||
| Granulomatous-lymphocytic interstitial lung disease : an international research prioritisation | ERJ open research | | 2021 | 29 | 12 | ||
| Un exemple de réorganisation dans le fonctionnement d’un Centre d’investigations cliniques en période de confinement national suite à la pandémie COVID-19 | Thérapie | | 2021 | 319 | 298 | ||
| Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia : A Randomized Clinical Trial | JAMA internal medicine | | 2021 | 51 | 36 | ||
| Management of early infection with Pseudomonas aeruginosa in adults with bronchiectasis : A survey of French pulmonologist's practices | Respiratory medicine and research | | 2021 | 30 | 0 | ||
| Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1) : a randomised controlled trial | The Lancet. Respiratory medicine | | 2021 | 45 | 9 | ||
| Bayesian survival analysis for early detection of treatment effects in phase 3 clinical trials | Contemporary clinical trials communications | | 2021 | 49 | 46 | ||
| Managing Granulomatous-Lymphocytic Interstitial Lung Disease in Common Variable Immunodeficiency Disorders : e-GLILDnet International Clinicians Survey | Frontiers in immunology | | 2020 | 40 | 23 | ||
| A Phase 2b, Randomized, Double-blind, Placebo-Controlled Multicenter Study Evaluating Antiviral Effects, Pharmacokinetics, Safety, and Tolerability of Presatovir in Hematopoietic Cell Transplant Recipients with Respiratory Syncytial Virus Infection of the Lower Respiratory Tract | Clinical infectious diseases | | 2020 | 29 | 13 | ||
| Pneumocytis jirovecii et PCR quantitative : pneumonie ou colonisation à Pneumocystis jirovecii ? | Revue des maladies respiratoires | | 2020 | 36 | 0 | ||
| Azithromycin Use and Increased Cancer Risk among Patients with Bronchiolitis Obliterans after Hematopoietic Cell Transplantation | Biology of blood and marrow transplantation | | 2020 | 31 | 53 | ||
| Pleuroparenchymal fibroelastosis after allogeneic hematopoietic stem cell transplantation | Bone marrow transplantation | | 2020 | 60 | 0 | ||
| A Phase 2, Randomized, Double-blind, Placebo-Controlled Trial of Presatovir for the Treatment of Respiratory Syncytial Virus Upper Respiratory Tract Infection in Hematopoietic-Cell Transplant Recipients | Clinical infectious diseases | | 2020 | 25 | 10 |
